The company's medical team evaluates eligibility based on body mass index (BMI), metabolic health markers, and medical history
Now, it's time for policymakers, employers and insurers to work with pharmaceutical companies to ensure no one is left behind in receiving the care they deserve and need." A four-week supply of the 2.5 mg Zepbound single-dose vial is $399 ($99.75 per vial), and a four-week supply of the 5 mg dose is $549 ($137.25 per vial) less than half the list price of other incretin medicines for obesity and in line with the Zepbound savings program for non-covered individuals
This dual action helps lower blood sugar levels and reduces food intake, contributing to effective weight loss
Do not try to compensate
We believe in a sustainable, flexible approach to nutrition, not restrictive dieting
Its considered weight-neutral, though some people may experience modest weight loss, and its unlikely to cause low blood sugar on its own